Tempest Therapeutics Inc

NASDAQ TPST

Data sourced from iex and EODHD
Download Data

Tempest Therapeutics Inc Income Statement 2011 - 2024

This table shows the Income Statement for Tempest Therapeutics Inc going from 2011 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 4 4 4 4 0 0 0 0 0 0 1 1 1 1 0 0 10 10 10 10 - - - - - - - - - - - -
Cost of Revenue
M 1 2 2 - - - - - - - - - - - - - - 4 4 4 4 0 0 1 1 2 4 4 5 5 5 3 2 1 0 0 - - - - - - - - - - - - -
Gross Profit
M -1 -2 -2 - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 -2 -3 -4 -5 -4 -4 -3 -2 9 10 10 10 - - - - - - - - - - - -
Operating Expenses
M 28 28 28 - - - - - - - - - - - - - - 9 15 20 27 26 29 40 46 53 62 63 71 74 74 74 70 79 62 45 28 - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 12 12 11 12 12 12 12 12 11 10 9 7 5 8 11 15 18 15 14 12 12 16 17 25 28 34 41 42 49 53 53 55 52 48 42 34 26 19 15 14 13 11 9 8 7 6 4 2 0
Research and Development (R&D) Expenses
M 17 17 19 21 22 23 21 20 19 17 15 15 15 19 24 27 29 29 23 18 14 10 13 15 18 19 20 21 22 22 21 19 18 21 22 23 22 22 20 18 16 11 9 8 6 4 3 1 0
Other Operating Expenses
M -1 -2 -2 - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10 10 10 10 - - - - - - - - - - - -
Costs and Expenses
M 28 27 28 - - - - - - - - - - - - - - 6 11 16 23 26 29 39 45 51 58 59 65 69 69 70 68 50 34 17 - - - - - - - - - - - - -
Operating Income
M -30 -29 -31 -33 -34 -35 -33 -32 -30 -27 -24 -22 -20 -27 -36 -42 -47 -44 -37 -30 -27 -26 -29 -40 -47 -55 -65 -67 -76 -79 -78 -77 -72 -70 -65 -57 -48 -41 -35 -32 -29 -22 -19 -16 -14 -10 -7 -4 -1
Interest Expense
M 1 1 2 2 2 2 2 2 1 1 1 1 0 0 0 1 1 1 1 0 0 - - - - 1 1 1 1 0 1 1 1 0 0 0 0 0 0 0 - - - - - - - - -
Non-operating Income/Expense
M 0 0 -1 -1 -1 -1 -1 -2 -2 -1 -4 -4 -9 -9 -6 -5 1 3 3 0 0 -3 -3 -3 -4 -10 -10 -8 -6 -1 -1 -1 -1 -1 -2 -2 -2 -1 0 0 0 0 0 0 0 0 - - -
EBT
M -30 -29 -31 -33 -35 -36 -34 -34 -31 -28 -25 -22 -20 -27 -35 -42 -46 -41 -34 -30 -27 -29 -33 -43 -51 -65 -75 -75 -82 -80 -79 -78 -73 -72 -67 -59 -50 -42 -36 -32 -29 -22 -18 -16 -14 -9 -6 -3 -
Income Tax Provision
M 0 0 1 2 2 2 1 1 1 1 -3 -4 -9 -10 -7 -6 0 3 3 0 0 -3 -3 0 0 0 0 0 0 0 0 0 -1 -1 -2 -2 -2 -1 0 0 0 0 0 0 - - - - -
Income after Tax
M -21 -22 -32 -35 -37 -38 -36 -35 -32 -29 -22 -19 -11 -17 -29 -36 -46 -43 -36 -30 -27 -26 -30 -43 -51 -65 -75 -75 -82 -80 -79 -77 -72 -70 -65 -57 -48 -41 -35 -32 -29 -18 -11 -5 - - - - -
Non-Controlling Interest
M 0 0 -2 -2 -2 -2 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income
M -8 -15 -23 -32 -33 -34 -34 -34 -31 -28 -21 -18 -16 -15 -15 -9 -4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 17,994,785.00 15,877,022.00 13,384,024.00 13,262,554.50 12,630,359.75 10,981,380.25 9,773,567.25 8,043,999.25 5,381,999.25 5,249,011.25 3,800,955.50 3,780,367.50 5,207,835.25 3,780,367.50 3,780,367.50 2,345,218.75 910,070.00 902,389.00 710,797.75 526,887.50 342,906.25 158,925.00 158,854.00 158,714.00 158,645.00 158,576.00 158,507.00 152,253.75 146,000.50 136,685.00 127,369.50 124,216.25 121,063.00 120,972.00 120,881.00 116,823.00 112,765.00 108,707.00 104,649.00 104,649.00 93,314.50 81,165.65 63,267.88 38,825.63 32,262.36 19,336.73 14,763.00 18,704.50 4,351.07
EBITDA
M -29 -29 -30 -31 -33 -33 -32 -32 -30 -27 -24 -21 -20 -27 -34 -41 -46 -41 -35 -30 -27 -28 -32 -42 -49 -63 -73 -73 -80 -78 -77 -76 -72 -71 -66 -58 -49 -41 -35 -31 -29 -22 -18 -16 -13 -10 -7 -4 -1
Depreciation and Amortization
M 0 1 1 1 1 1 1 1 0 0 0 0 1 1 2 2 1 1 -1 0 0 1 1 2 2 2 2 2 2 2 2 2 1 1 1 1 0 0 0 0 0 0 0 0 - - - - -
EBIT
M -29 -29 -31 -33 -34 -35 -33 -32 -30 -27 -24 -22 -20 -27 -36 -42 -47 -41 -34 -30 -27 -29 -33 -43 -51 -65 -75 -75 -82 -80 -79 -78 -73 -72 -67 -59 -50 -42 -36 -32 -29 -18 -11 -5 - - - - -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 1.83 -2.02 -3.97 -4.78 -5.32 -4.99 -4.37 -4.07 -3.01 -3.92 15.50 20.02 47.39 49.33 31.82 27.75 0.45 -10.12 -10.93 -2.45 -0.88 9.53 10.23 1.48 -0.16 -0.04 -0.14 -0.18 -0.26 -0.37 -0.04 0.48 1.14 2.03 2.83 3.13 3.09 2.26 1.12 0.27 -0.34 -0.42 -0.38 -0.35 - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% - - - - - - - - - - - - - - - - - 0.20 10.10 17.84 -3.41 -38.35 -31.29 -96.18 -161.13 -397.31 -582.21 -663.76 -758.38 -646.70 -762.19 -695.76 -552.73 -368.33 -106.67 -16.67 100.00 - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - - - - - -256.74 -5,442.00 -5,690.55 -6,838.81 -9,108.69 -10,489.82 -13,686.36 -16,313.48 -17,485.20 -15,853.85 -13,523.23 -11,996.28 -11,713.42 -15,230.82 -27,129.66 -51,480.26 -48,304.30 -56,507.07 -56,137.27 -187.87 - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - - - -198.06 -5,146.30 -6,528.40 -7,523.16 -9,714.03 -11,206.47 -14,146.12 -17,243.46 -19,562.17 -17,909.17 -15,021.37 -12,923.70 -11,547.41 -15,045.68 -27,093.18 -51,764.97 -48,630.19 -57,025.15 -56,692.72 -192.11 - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - - - - - -181.15 -5,253.30 -6,672.16 -7,754.12 -10,042.35 -11,637.77 -14,668.93 -17,826.08 -20,174.17 -18,433.81 -15,474.65 -13,280.35 -11,867.21 -15,404.78 -27,530.31 -52,494.14 -49,274.18 -57,733.57 -57,450.35 -194.04 - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - - - - - -180.73 -5,253.09 -6,672.02 -7,754.02 -10,042.35 -11,637.77 -14,668.93 -17,826.08 -20,174.17 -18,433.81 -15,474.65 -13,280.35 -11,867.21 -15,404.78 -27,530.31 -52,494.14 -49,274.18 -57,733.57 -57,450.35 -194.04 - - - - - - - - - - - -

StockViz Staff

September 20, 2024

Any question? Send us an email